Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Combining more than one drug may kill more cancer cells.
PURPOSE: Phase II trial to study the effectiveness of combining lomustine, etoposide,
cyclophosphamide, and procarbazine in treating patients who have AIDS-related non-Hodgkin's
lymphoma.